| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 |
| filingDate |
1998-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f26fd44d90cc67bcc159762ef19db93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afac960de8c94ecea37b5111cce9c029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0007f5cc9df08bb3acc78d87b9cf2621
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70ac92fd1f5cccac3b3393e5be4ff2d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f235f1ec1e15c7dddfee0bf2ea4a8b64 |
| publicationDate |
2000-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-9807523-A |
| titleOfInvention |
Quinoxalins in triple combination with protease inhibitors and reverse transcriptase inhibitors as drugs for the treatment of AIDS. |
| abstract |
the use of quinoxalins in triple combination with protease inhibitors and AIDS transporter inhibitors and / or HIV infections. |
| priorityDate |
1997-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |